Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Thomason

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Frontiers in Public Health|December 16, 2020
COVID-19-Zoonosis or Emerging Infectious Disease?Najmul Haider, Peregrine Rothman-Ostrow, Abdinasir Yusuf Osman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 11, 2020
Noncoding Microdeletion in Mouse <i>Hgf</i> Disrupts Neural Crest Migration into the Stria Vascularis, Reduces the Endocochlear Potential, and Suggests the Neuropathology for Human Nonsyndromic Deafness DFNB39Robert J Morell, Rafal Olszewski, Risa Tona, et al.
Contemporary Clinical Trials|May 31, 2025
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan AfricaFredrick Katongole, Tiyara Arumugam, Angus Jennings, et al.
Annals of Clinical Microbiology and Antimicrobials|April 13, 2023
A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settingsLinzy Elton, Muzamil Mahdi Abdel Hamid, John Tembo, et al.
Trials|December 31, 2015
Transfusion and Treatment of severe anaemia in African children (TRACT): a study protocol for a randomised controlled trialAyub Mpoya, Sarah Kiguli, Peter Olupot-Olupot, et al.
The New England Journal of Medicine|July 21, 2017
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in AfricaJames Hakim, Victor Musiime, Alex J Szubert, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
Contemporary Clinical Trials|January 9, 2026
Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan AfricaDiana Anena, Elizabeth Chappell, Rashidah Nazzinda, et al.
The Lancet. Global Health|September 21, 2019
Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trialKathryn Maitland, Peter Olupot-Olupot, Sarah Kiguli, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Frontiers in Public Health|December 16, 2020
COVID-19-Zoonosis or Emerging Infectious Disease?Najmul Haider, Peregrine Rothman-Ostrow, Abdinasir Yusuf Osman, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 11, 2020
Noncoding Microdeletion in Mouse <i>Hgf</i> Disrupts Neural Crest Migration into the Stria Vascularis, Reduces the Endocochlear Potential, and Suggests the Neuropathology for Human Nonsyndromic Deafness DFNB39Robert J Morell, Rafal Olszewski, Risa Tona, et al.
Contemporary Clinical Trials|May 31, 2025
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan AfricaFredrick Katongole, Tiyara Arumugam, Angus Jennings, et al.
Annals of Clinical Microbiology and Antimicrobials|April 13, 2023
A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settingsLinzy Elton, Muzamil Mahdi Abdel Hamid, John Tembo, et al.
Trials|December 31, 2015
Transfusion and Treatment of severe anaemia in African children (TRACT): a study protocol for a randomised controlled trialAyub Mpoya, Sarah Kiguli, Peter Olupot-Olupot, et al.
The New England Journal of Medicine|July 21, 2017
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in AfricaJames Hakim, Victor Musiime, Alex J Szubert, et al.
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
Contemporary Clinical Trials|January 9, 2026
Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan AfricaDiana Anena, Elizabeth Chappell, Rashidah Nazzinda, et al.
The Lancet. Global Health|September 21, 2019
Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trialKathryn Maitland, Peter Olupot-Olupot, Sarah Kiguli, et al.
Pageof 16